A phase II study of PTX 9908 for the treatment of liver cancer.

Trial Profile

A phase II study of PTX 9908 for the treatment of liver cancer.

Planning
Phase of Trial: Phase II

Latest Information Update: 16 Feb 2016

At a glance

  • Drugs PTX 9908 (Primary)
  • Indications Liver cancer
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 16 Feb 2016 New trial record
    • 17 Dec 2014 According to a TCM Biotech media release, the company plans to apply for phase II clinical trials in Taiwan in the first half of 2015.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top